Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Casellas

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
European Journal of Pharmacology|November 27, 2002
SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory propertiesBernard Bourrié, Estelle Bribes, Nathalie De Nys, et al.
Cancer Research|August 28, 2003
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding proteinHubert Vidal, Guillaume Mondesert, Sylvaine Galiègue, et al.
The American Journal of Pathology|April 12, 2002
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivoL'Houcine Ouafik, Samantha Sauze, Françoise Boudouresque, et al.
Leukemia & Lymphoma|November 6, 2012
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemiasBernard Bourrié, Diana L Brassard, Sylvie Cosnier-Pucheu, et al.
Cancer Research|October 3, 2003
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical modelsBruce Ruggeri, Jasbir Singh, Diane Gingrich, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
European Journal of Pharmacology|November 27, 2002
SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory propertiesBernard Bourrié, Estelle Bribes, Nathalie De Nys, et al.
Cancer Research|August 28, 2003
Identification and pharmacological characterization of SRBP-2: a novel SR31747A-binding proteinHubert Vidal, Guillaume Mondesert, Sylvaine Galiègue, et al.
The American Journal of Pathology|April 12, 2002
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivoL'Houcine Ouafik, Samantha Sauze, Françoise Boudouresque, et al.
Leukemia & Lymphoma|November 6, 2012
SAR103168: a tyrosine kinase inhibitor with therapeutic potential in myeloid leukemiasBernard Bourrié, Diana L Brassard, Sylvie Cosnier-Pucheu, et al.
Cancer Research|October 3, 2003
CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical modelsBruce Ruggeri, Jasbir Singh, Diane Gingrich, et al.
Pageof 3